Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kouichi Asano

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 6, 2011
[Recent advances in genetic research of inflammatory bowel disease]Kouichi Asano, Junji Umeno, Takayuki Matsumoto
Gastrointestinal Endoscopy|April 29, 2004
Metastatic duodenal carcinoid tumorSebastião Mitsuji Miyazaki, Shuji Tada, Kouichi Asano, et al.
Journal of Gastroenterology and Hepatology|January 23, 2014
Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximabShin Fujioka, Ikuo Nakamichi, Motohiro Esaki, et al.
Gastrointestinal Endoscopy|October 9, 2004
StrongyloidiasisKouichi Asano, Shuji Tada, Takihiro Kamio, et al.
Journal of Hepatology|June 28, 2005
A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reportsKouichi Asano, Shuji Tada, Takayuki Matsumoto, et al.
Inflammatory Bowel Diseases|February 26, 2011
Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitisJunji Umeno, Kouichi Asano, Tomonaga Matsushita, et al.
Journal of Gastroenterology|March 20, 2015
Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitisKouichi Asano, Motohiro Esaki, Junji Umeno, et al.
Scandinavian Journal of Gastroenterology|January 29, 2016
Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experienceYoichiro Nuki, Motohiro Esaki, Kouichi Asano, et al.
Digestion|January 31, 2015
Therapeutic strategy for Crohn's disease with a loss of response to infliximab: a single-center retrospective studyYutaka Nagata, Motohiro Esaki, Junji Umeno, et al.
International Journal of Cancer|October 25, 2007
Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama studyKouichi Asano, Michiaki Kubo, Koji Yonemoto, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 6, 2011
[Recent advances in genetic research of inflammatory bowel disease]Kouichi Asano, Junji Umeno, Takayuki Matsumoto
Gastrointestinal Endoscopy|April 29, 2004
Metastatic duodenal carcinoid tumorSebastião Mitsuji Miyazaki, Shuji Tada, Kouichi Asano, et al.
Journal of Gastroenterology and Hepatology|January 23, 2014
Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximabShin Fujioka, Ikuo Nakamichi, Motohiro Esaki, et al.
Gastrointestinal Endoscopy|October 9, 2004
StrongyloidiasisKouichi Asano, Shuji Tada, Takihiro Kamio, et al.
Journal of Hepatology|June 28, 2005
A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reportsKouichi Asano, Shuji Tada, Takayuki Matsumoto, et al.
Inflammatory Bowel Diseases|February 26, 2011
Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitisJunji Umeno, Kouichi Asano, Tomonaga Matsushita, et al.
Journal of Gastroenterology|March 20, 2015
Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitisKouichi Asano, Motohiro Esaki, Junji Umeno, et al.
Scandinavian Journal of Gastroenterology|January 29, 2016
Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experienceYoichiro Nuki, Motohiro Esaki, Kouichi Asano, et al.
Digestion|January 31, 2015
Therapeutic strategy for Crohn's disease with a loss of response to infliximab: a single-center retrospective studyYutaka Nagata, Motohiro Esaki, Junji Umeno, et al.
International Journal of Cancer|October 25, 2007
Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama studyKouichi Asano, Michiaki Kubo, Koji Yonemoto, et al.
Pageof 2